Bell Rock Capital’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,000
Closed -$127K 247
2019
Q4
$127K Hold
4,000
0.11% 143
2019
Q3
$98K Sell
4,000
-1,200
-23% -$30.5K 0.09% 153
2019
Q2
$137K Sell
5,200
-2,812
-35% -$69.7K 0.12% 132
2019
Q1
$209K Buy
8,012
+1,616
+25% +$40.7K 0.12% 124
2018
Q4
$145K Sell
6,396
-400
-6% -$10.3K 0.1% 135
2018
Q3
$197K Sell
6,796
-2,004
-23% -$52.7K 0.1% 131
2018
Q2
$199K Buy
8,800
+4
+0% +$88 0.1% 136
2018
Q1
$188K Sell
8,796
-584
-6% -$13.6K 0.1% 135
2017
Q4
$207K Hold
9,380
0.11% 125
2017
Q3
$201K Sell
9,380
-2,000
-18% -$41K 0.11% 125
2017
Q2
$228K Buy
11,380
+3,400
+43% +$62.7K 0.14% 110
2017
Q1
$140K Sell
7,980
-2,000
-20% -$33.6K 0.13% 100
2016
Q4
$150K Buy
+9,980
New +$151K 0.16% 98

Other funds holding RXL

Bell Rock Capital's RXL Position: Q1 2020 in Review

Bell Rock Capital sold out of ProShares Ultra Health Care (RXL) in Q1 2020, closing a stake of 4,000 shares — an estimated $127K sold.

Bell Rock Capital first reported a position in RXL in Q4 2016 and held it in 13 quarters. The position peaked at $228K in Q2 2017. 20 funds tracked by Wall St. Rank hold RXL as of Q1 2020.

  • Bell Rock Capital reported no remaining ProShares Ultra Health Care position as of Q1 2020 after selling out during the quarter.
  • Bell Rock Capital sold 4,000 ProShares Ultra Health Care shares in Q1 2020, an estimated $127K.
  • Bell Rock Capital first reported a position in ProShares Ultra Health Care in Q4 2016 and held it in 13 quarters.
  • Bell Rock Capital's ProShares Ultra Health Care position peaked at $228K in Q2 2017.
  • 20 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2020.

Based on Bell Rock Capital's 13F filing for Q1 2020, filed 7 May 2020.